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ABSTRACT: Opening and closing of the cystic ﬁbrosis transmembrane
conductance regulator chloride channel are controlled by interactions of
ATP with its cytoplasmic nucleotide binding domains (NBDs). The
NBDs are connected to the transmembrane pore via four cytoplasmic
loops. These loops have been suggested to play roles both in channel
gating and in forming a cytoplasmic extension of the channel pore. To
investigate the structure and function of one of these cytoplasmic loops,
we have used patch clamp recording to investigate the accessibility of
cytoplasmically applied cysteine-reactive reagents to cysteines introduced
into loop 3. We ﬁnd that methanethiosulfonate (MTS) reagents modify
cysteines introduced at 14 of 16 sites studied in the juxtamembrane
region of loop 3, in all cases leading to inhibition of channel function. In most cases, both the functional eﬀects of modiﬁcation
and the rate of modiﬁcation were similar for negatively and positively charged MTS reagents. Single-channel recordings indicated
that, at all sites, inhibition was the result of an MTS reagent-induced decrease in channel open probability; in no case was the Cl−
conductance of open channels altered by modiﬁcation. These results indicate that loop 3 is readily accessible to the cytoplasm
and support the involvement of this region in the control of channel gating. However, our results do not support the hypothesis
that this region is close enough to the Cl− permeation pathway to exert any inﬂuence on permeating Cl− ions. We propose that
either the cytoplasmic pore is very wide or cytoplasmic Cl− ions use other routes to access the transmembrane pore.
C
ystic ﬁbrosis is caused by loss of function mutations in the
cystic ﬁbrosis transmembrane conductance regulator
(CFTR) Cl− channel, a member of the ATP-binding cassette
(ABC) family of ATP-dependent membrane transport proteins.
All ABC proteins share a common modular architecture,
consisting of two membrane-spanning domains (MSDs) that
form the substrate translocation pathway and two cytoplasmic
nucleotide binding domains (NBDs) that bind and hydrolyze
ATP (Figure 1). In CFTR, an additional cytoplasmic regulatory
domain (R domain) is the site of regulation by PKA-dependent
phosphorylation. Consistent with this ABC architecture, several
transmembrane (TM) α-helices
1−3 and extracellular loops
(ELs)
4,5 have been shown to contribute to the Cl− channel
pore in CFTR. The activity of the channel is controlled by ATP
interactions at the NBDs,
6,7 which leads to the opening and
closing of a “gate” located in the MSDs.
8
The NBDs are not in direct contact with the TMs but instead
are connected indirectly via the long cytoplasmic loops (CLs)
that are located between individual TMs (Figure 1). Structural
models of the CFTR protein
9−11 therefore suggest that NBD−
CL interactions should be important in coupling ATP action at
the NBDs to channel opening in the MSDs. In fact, the role of
the CLs in forming a physical and functional link between the
NBDs and the transmembrane substrate translocation pathway
may be conserved among all ABC proteins.
12,13 The location of
the CLs below the TMs (Figure 1A) also suggests that the CLs
could form a cytoplasmic extension of the permeation pathway
for Cl− ions. In fact, on the basis of these models, it has been
suggested that the CLs form a narrow “funnel” connecting the
TMs to the cytoplasm (Figure 1C), and that this CL funnel,
not the TMs, forms the narrowest part of the Cl− channel pore
where channel opening and closing may occur.
11
Functional evidence also supports a role for NBD−CL
interactions in ATP-dependent channel gating (pore opening
and closing). For example, CL3, located between TM8 and
TM9 (Figure 1), interacts with both NBDs
14 as well as the R
domain
15,16 to regulate gating. Mutations within CL3 also aﬀect
gating,
17,18 perhaps by disrupting communication between the
NBDs and the gate in the MSDs.
19 CF-associated mutations in
this loop also disrupt processing and traﬃcking of CFTR
protein to the membrane,
17,20 perhaps highlighting the
importance of domain−domain interactions in proper protein
folding,
10,21−23 although CL3 has also been implicated in
ubiquitination-dependent CFTR traﬃcking.
24 There is also
some functional evidence that CL3 may contribute to the Cl−
permeation pathway. The CF-associated mutations S945L and
G970R were shown to have very slightly altered single-channel
Cl− conductance.
17 Furthermore, the positive charge associated
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cytoplasmic channel blocking substances.
25,26 However, the
role of CL3 in channel function has not previously been
addressed in a comprehensive way.
To investigate the possibility that CL3 forms a cytoplasmic
extension of the CFTR pore, we have undertaken a substituted
cysteine accessibility mutagenesis (SCAM) study of the
juxtamembrane parts of this loop. Because residues within the
CLs have not previously been directly demonstrated to
contribute to the permeation pathway, we reasoned that this
region relatively close to the TMs might be considered most
likely to inﬂuence Cl− permeation. Furthermore, more
cytoplasmic parts of CL3 are likely to be involved in
interactions with NBD1.
9,10,14 We have used SCAM because
of the proven power of this approach in identifying amino acids
that contribute to the CFTR permeation pathway.
2,3,27−30 Our
results indicate that the juxtamembrane regions of CL3 are
exposed to the cytoplasm and are readily modiﬁed by
intracellular cysteine-reactive methanethiosulfonate (MTS)
reagents. However, the eﬀects of modiﬁcation appear to reﬂect
changes in channel gating, rather than channel permeation
properties. These results suggest that while CL3 plays a role in
the coordination of ATP-dependent gating, it does not make an
important functional contribution to the Cl− permeation
pathway.
■ MATERIALS AND METHODS
Experiments were conducted on baby hamster kidney (BHK)
cells transiently transfected with CFTR. As in our recent
SCAM-based studies of individual TMs,
2,28,30 we have used a
human CFTR variant from which all cysteines had been
removed by mutagenesis (as described in ref 31) and which
includes a mutation in NBD1 (V510A) to increase the level of
protein expression in the cell membrane.
32 Use of this Cys-less
variant is necessary for these studies because wild-type CFTR is
potently inhibited by cytoplasmic MTS reagents.
33 However, in
Figure 1. Location of CL3 within the overall structure of CFTR. The CFTR protein consists of two MSDs and two NBDs, joined by a cytoplasmic R
domain. Each MSD consists of six TM helices connected by three ELs and two CLs. (A) Proposed overall structure of CFTR (viewed from the
side), based on atomic homology modeling of bacterial ABC protein Sav1866.
10 TMs that are known to line the Cl− channel pore are colored red
(from left to right, TM1, TM6, and TM12, respectively). The locations of TM8 (left) and TM9 (right) are colored blue. Connecting these two TMs
is CL3, which is colored blue, with the region mutated in this study colored gold. (B) Isolated TM8−CL3−TM9 region from the same model,
showing the juxtamembrane region of this CL as a cytoplasmic extension of these two TMs. (C) Position of the CLs around a narrow “funnel”
region in the cytoplasm, as viewed from above. Other parts of the protein have been removed for the sake of clarity. The part of CL3 that appears to
line this narrow region is that proximal to TM9. Illustrations were prepared using PyMOL based on the structure presented by Serohijos et al.
10 (D)
Two-dimensional topology of CFTR, illustrating two MSDs, two NBDs, the R domain (RD), and 12 TMs. The coloring of the TMs is the same as
that in panel A. The region mutated in this study is enclosed in the dotted box, which is magniﬁed in panel E. This shows the amino acid sequence of
CL3, from P936 at the cytoplasmic end of TM8 to P988 at the cytoplasmic end of TM9. As in panels A−C, residues mutated in this study (L941−
K951 and L973−L983) are colored gold.
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34,35 Cys-less CFTR has
b e e nr e p o r t e dt oh a v eg a t i n g
31,36 and permeation
31,36,37
properties subtly diﬀerent from those of wild-type CFTR.
Additional mutations were introduced into the Cys-less
background using the QuikChange site-directed mutagenesis
system (Agilent Technologies, Santa Clara, CA) and veriﬁed by
DNA sequencing. Mutations were introduced into the
juxtamembrane regions of CL3, replacing each consecutive
amino acid between L941 and K951 (in the cytoplasmic
extension from TM8) and from L973 to L983 (in the
cytoplasmic extension from TM9) individually with cysteine
(Figure 1E). BHK cells were transiently transfected as
described previously,
38 except that 24 h after transfection
cells were transferred to 27 °C to promote mature protein
expression.
32 Cells were used for Western blotting analysis after
48 h at 27 °C, and for electrophysiological experimentation
after 1−3 days at 27 °C.
For Western blotting, cells at ∼80% conﬂuence were washed
twice with ice-cold PBS, harvested by being scraped, and lysed
on ice for 30 min in RIPA buﬀer supplemented with protease
inhibitors. Cells were lysed by repeated vortexing as well as by
passing the lysate through a pipet tip every 5 min. The lysate
was then centrifuged (15000g for 30 min at 4 °C) and the
supernatant poured into a fresh tube. The protein concen-
tration was assayed using the Bradford protein assay method.
Approximately 30 μg of protein was preincubated with an equal
volume of loading buﬀer for 30 min at 37 °C and then loaded
onto a 7.5% acrylamide−SDS gel and ﬁnally transferred to an
Immobilon-P membrane (Millipore, Bedford, MA). Immuno-
blotting for CFTR was performed by incubating the membrane
overnight at 4 °C with monoclonal mouse anti-CFTR antibody
(M3A7, Millipore) at a 1:1000 dilution. After being washed, the
membrane was incubated for 1 h at room temperature with a
secondary antibody (horseradish peroxidase-conjugated goat
anti-mouse, Jackson ImmunoResearch, West Grove, PA) at a
1:5000 dilution. Detection was conducted using the ECL Plus
kit (Amersham Pharmacia, Baie d’Urfe, QC) following the
manufacturer’s instructions. The relative expression of mature,
complex glycosylated CFTR protein (“Band C”) and immature,
core glycosylated protein (“Band B”) was assessed by
densitometric analysis of scanned Western blots using 1-D
(Bio-Rad, Hercules, CA).
Macroscopic and single-channel recordings were made using
the excised, inside-out conﬁguration of the patch clamp
technique. CFTR channels were activated after patch excision
and recording of background currents by exposure to protein
kinase A catalytic subunit (PKA, 20 nM) and MgATP (1 mM)
in the cytoplasmic solution. For macroscopic current record-
ings, both the intracellular (bath) and extracellular (pipet)
solution contained 150 mM NaCl, 10 mM N-tris-
(hydroxymethyl)methyl-2-aminoethanesulfonate, and 2 mM
MgCl2. For single-channel recordings, NaCl in the pipet
solution was replaced with 150 mM sodium gluconate to
generate an outwardly directed Cl− concentration gradient.
This was done to allow CFTR single-channel currents to be
resolved at a membrane potential of −20 mV during the
prolonged recordings necessary for measurement of channel
open probability (see Figure 7). During preliminary recordings,
we found that inside-out patches held at more negative or
positive membrane potentials using the same symmetrical Cl−
solutions used for macroscopic current recordings were
unstable over these prolonged recording periods. The trans-
membrane Cl− concentration gradient is not expected to
inﬂuence any of the parameters measured in our experiments.
All experimental solutions were adjusted to pH 7.4.
Channels were exposed to intracellular cysteine-reactive
MTS reagents to covalently modify an introduced cysteine side
chain. Two MTS reagents, the negatively charged [2-
sulfonatoethyl] MTS (MTSES) and the positively charged
[2-(trimethylammonium)ethyl] MTS (MTSET) were used at
high concentrations (200 μM) that had no eﬀect on Cys-less
CFTR.
28,32 MTS reagents were applied to the cytoplasmic face
of inside-out patches after stable current activation with PKA
and ATP, and the current was monitored for at least 5 min to
ensure stable modiﬁcation. In some cases, the identity of the
remaining currents as being carried by CFTR was conﬁrmed
using the CFTR-speciﬁc inhibitor CFTRinh-172. To measure
the rate of modiﬁcation, the macroscopic current amplitude was
monitored continuously and the time-dependent change in
amplitude after the addition of MTS reagent was ﬁtted by a
single-exponential function. The time constant of exponential
current decay, τ, was then used to calculate the apparent
second-order reaction rate constant, k, from the equation k =1 /
([MTS]τ).
Current traces were ﬁltered at 100 Hz (macroscopic
currents) or 50 Hz (single-channel currents) using an eight-
pole Bessel ﬁlter, digitized at 250 Hz, and analyzed using
pCLAMP9 (Molecular Devices, Sunnyvale, CA). Macroscopic
current−voltage (I−V) relationships were constructed using
voltage ramp protocols from a holding potential of 0 mV. The
single-channel current amplitude and channel open probability
were estimated from all-points amplitude histograms (Figure
7). For analysis of the eﬀects of MTSES on single-channel
currents, currents were recorded for at least 5 min at a
membrane potential of −20 mV under control conditions to
ensure stable channel activity, following which MTSES was
applied to the cytoplasmic face of the patch and currents were
recorded for a further 5−12 min. Because channel open
probability was highly variable between patches (see Figure S2
of the Supporting Information), we have focused on the eﬀect
of MTSES exposure on open probability, which we found to be
considerably more consistent (Figure 8B).
Experiments were conducted at room temperature (21−24
°C). Values are presented as means ± the standard error of the
mean. Tests of signiﬁcance were conducted using an unpaired t
test, for which p < 0.05 was considered statistically signiﬁcant.
All chemicals were obtained from Sigma-Aldrich (Oakville,
ON), except MTSES and MTSET (Toronto Research
Chemicals, North York, ON) and PKA (Promega, Madison,
WI).
■ RESULTS
Expression of CL3 Mutants in a Cys-less CFTR
Background. We used site-directed mutagenesis to introduce
cysteines into the juxtamembrane region of CL3 (Figure 1).
Cysteines were substituted for each amino acid from L941 to
K951 in the cytoplasmic extension from TM8, and from L973
to L983 in the extension from TM9 (Figure 1E). Mutant
CFTR was expressed in BHK cells, and proper processing of
the CFTR protein was assayed using Western blot analysis. As
shown in Figure 2, Cys-less CFTR was able to generate mature,
complex glycosylated (Band C) protein, although the relative
abundance of this mature form was lower than that of wild-type
CFTR. Previously, we have shown that the ability of Cys-less to
produce Band C protein in BHK cells is dependent on (i) the
growth of the cells at a reduced temperature of 27 °C and (ii)
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32 In contrast to
the Cys-less background, almost all CL3 cysteine mutants
studied gave almost undetectable levels of Band C protein
(Figure 2), suggesting that mutations in this juxtamembrane
region result in serious misprocessing of the CFTR protein.
Eﬀects of the MTS Reagents on Macroscopic
Currents. Functional properties of mutant CFTR expressed
in BHK cells were investigated using inside-out patch
recording. Sixteen of the 22 mutants that were constructed
generated macroscopic PKA- and ATP-dependent currents in
inside-out membrane patches (e.g., Figure 3). However, for the
six remaining mutants (S945C, L948C, H949C, K951C,
K978C, and D979C), application of PKA and ATP consistently
failed to generate a signiﬁcant increase in the macroscopic
current amplitude above background levels. Each of these six
mutants was also associated with undetectable levels of mature,
Band C protein (Figure 2), suggesting that these mutants were
misprocessed and absent from the cell membrane. However,
other CL3 mutants with similar apparent misprocessing as
determined by Western blotting (Figure 2) did generate
measurable macroscopic currents. Our favored interpretation of
this apparent discrepancy is that our patch clamp experiments
are, in fact, able to detect tiny amounts of CFTR protein in the
cell membrane that cannot be detected by Western blotting,
either because the amount of mature Band C protein is below
detection levels or because some immature Band B protein is
present at the membrane. However, on the basis of our results,
we cannot rule out the alternative explanation that S945C,
L948C, H949C, K951C, K978C, and D979C are also present at
the cell membrane but that these mutants generate CFTR
channels that are functionally nonresponsive to PKA and ATP.
For those 16 CL3 mutants that could be studied functionally,
modiﬁcation of introduced cysteines by negatively charged
MTSES and positively charged MTSET was investigated by
application of these reagents to the cytoplasmic face of inside-
out membrane patches following channel activation by PKA
and ATP. Three diﬀerent types of functional eﬀects were
observed. In most cases (L941C, I942C, K946C, I947C,
H950C, L973C, N974C, S977C, I980C, A981C, and I982C),
macroscopic currents were inhibited by both MTSES and
MTSET (e.g., Figure 3A). In contrast, T943C, V944C, and
R975C were inhibited by MTSES but not signiﬁcantly aﬀected
by MTSET exposure (e.g., Figure 3B). Two mutants, F976C
and L983C, were not signiﬁcantly aﬀected by either MTSES or
MTSET (e.g., Figure 3C), as recently demonstrated for Cys-
less using similar protocols
28,30 (Figure 4). The shape of the
macroscopic I−V relationship was nearly linear for Cys-less
CFTR
28 and was not signiﬁcantly altered by any of the
mutations studied, nor did modiﬁcation by either MTSES or
MTSET have any signiﬁcant eﬀect on the shape of the I−V
relationship (Figure 3D,E and Figure S1 of the Supporting
Information). The eﬀects of MTS reagents on the amplitude of
macroscopic currents carried by diﬀerent channel constructs are
summarized in Figure 4. The rate of modiﬁcation of introduced
cysteines was quantiﬁed from the time course of macroscopic
current amplitude change following application of MTSES or
MTSET (Figure 5).
Eﬀects of MTSES on Single-Channel Currents. To
further characterize the nature of the inhibitory eﬀects of MTS
reagents on cysteine-substituted CL3 mutants, we recorded
single-channel currents carried by these mutants in inside-out
patches. For technical reasons, single-channel recordings were
taken using a low extracellular Cl− concentration of 4 mM (see
Materials and Methods). Under these conditions, all channel
constructs studied had identical single-channel conductance,
even where the mutation involved removal of a positive charge
(K946C and R975C) (Figure 6). Note that those six mutants
that failed to generate macroscopic currents (see above) were
also not associated with detectable single-channel currents.
We restricted our single-channel studies to the use of
MTSES, because this reagent had more consistent eﬀects on
cysteine-substituted CL3 mutants [i.e., all MTS-sensitive
mutants were inhibited by MTSES, although not all were
inhibited by MTSET (Figure 4)] and also because we
considered modiﬁcation by this negatively charged substance
more likely to interfere electrostatically with Cl− permeation
and so more likely to inﬂuence Cl− conductance.
28−30 In fact,
in most cases, MTSES and MTSET had similar eﬀects on
macroscopic current amplitudes (Figure 4). The approach we
followed is illustrated in Figure 7, using I982C as an example.
PKA- and ATP-stimulated single-channel currents were
recorded for >5 min to ensure stable activation, following
which MTSES was applied to the intracellular solution. In the
example shown in Figure 7, it can be seen that the application
of MTSES reduced the open probability of the channel to
∼55% of the control, without aﬀecting the single-channel
current amplitude. Eﬀects of MTSES on both unitary current
amplitude and open probability were quantiﬁed using all-points
amplitude histograms constructed from data before and after
MTSES exposure (e.g., Figure 7B). This data for all channel
Figure 2. Protein expression of CL3 mutants. (A) Representative
Western blot for CFTR using protein from BHK cells transfected with
the wild type, the Cys-less mutant, or the named cysteine mutants in a
Cys-less background. Note the near absence of Band C protein for
these mutants. (B) Mean abundance of Band C protein (as a
percentage of total). Only R975C was not signiﬁcantly diﬀerent from
the Cys-less mutant (p > 0.6); for H950C and L983C, p < 0.05, and
for all other mutants, p < 0.00005. Means of data from nine
independent transfections for Cys-less and three to six for other
constructs are shown.
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MTSES exposure signiﬁcantly aﬀect single-channel current
amplitude (Figure 8A). In contrast, for all mutants for which
MTSES exposure reduced macroscopic current amplitudes
(Figure 4), MTSES also caused a reduction in open probability
(Figure 8B). MTSES did not aﬀect open probability in Cys-less,
or in two mutants that were not sensitive to MTSES at the
macroscopic current level [F976C and L983C (Figure 4)]
(Figure 8B), suggesting that it is an MTSES-induced reduction
in open probability that is responsible for the reduction in
Figure 3. Modiﬁcation of cysteines introduced into CL3 by internal MTS reagents. (A−C) Example time courses of macrosopic currents (measured
at −50 mV) carried by L941C (A), V944C (B), and L983C (C). After patch excision and recording of baseline currents, patches were treated
sequentially with 20 nM PKA and 1 mM ATP (hatched bars), 200 μM MTS reagent (left panels, MTSES, black bars; right panels, MTSET, white
bars), and 5 μM CFTRinh-172 (gray bars). (D and E) I−V relationships for the patches shown in panels A and B following maximal current
stimulation with PKA and ATP (control), following addition of MTSES (left panels) or MTSET (right panels), and following addition of CFTRinh-
172 (+Inh).
Figure 4. Eﬀects of internal MTS reagents on macroscopic current amplitudes. Mean eﬀect of treatment with 200 μM MTSES (black bars) or
MTSET (white bars) on the macroscopic current amplitude measured at −50 mV, for Cys-less CFTR and each of the cysteine-substituted CL3
mutants named. Mutants that did not yield measurable macroscopic currents in inside-out patches are shown in parentheses. Means of data from
three or four patches are shown. Asterisks indicate a signiﬁcant diﬀerence from the value of Cys-less (p < 0.05).
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observed in Figure 4.
■ DISCUSSION
Of 22 cysteine mutations introduced into CL3, 21 appeared to
be associated with a signiﬁcant defect in protein processing
relative to the Cys-less background, as determined by
densitometric analysis of production of mature CFTR protein
(Figure 2). Superﬁcially, this might appear to support an
important, and relatively non-site-speciﬁc, role for CL3 in
normal CFTR processing (see the introductory section).
However, Cys-less CFTR itself has a severe protein
misprocessing defect
32,34,35 that in this study has been partially
ameliorated by a rescue mutation in NBD1 (V510A) and by
growing transfected BHK cells at a reduced temperature of 27
°C (see Materials and Methods). Thus, the relevance of these
ﬁndings for the processing of wild-type CFTR is uncertain, as is
the rationale for studying traﬃcking in a Cys-less CFTR
background.
Interestingly, many CL3 mutants could be studied function-
ally in spite of an apparent lack of mature protein (Figure 2).
We believe this most likely reﬂects the sensitivity of our patch
clamp assay to the presence of even very small amounts of
CFTR in the cell membrane. Only six mutants (S945C, L948C,
H949C, K951C, K978C, and D979C) failed to generate
functional channels in inside-out membrane patches (Figure 4).
Each of these six was associated with undetectable Band C
protein by Western blotting (Figure 2), consistent with the
failure of traﬃcking of these mutants to the cell membrane.
Misprocessing of CF-associated mutants S945L, H949Y, and
D979A has previously been demonstrated,
17,20 perhaps
indicating that these residues are particularly critical for normal
protein processing. However, because our work failed to show a
direct correlation between protein processing determined
biochemically (Figure 2) and function determined electro-
physiologically (Figure 4), we cannot rule out the possibility
that the six nonfunctional mutants are present in the cell
membrane but nonfunctional for other reasons, such as a failure
to open in response to ATP and PKA or an undetectably low
single-channel conductance.
Interestingly, one mutant that failed to express functional
channels in our hands (K978C) has previously been studied in
a Cys-less background by patch clamp recording by others
18
Figure 5. Rate of modiﬁcation by MTSES and MTSET. (A and B) Example time courses of macroscopic currents (measured at −50 mV) carried by
I942C (A) and I947C (B). Current ampliutes were measured every 6 s after attainment of stable current amplitude following activation by PKA (20
nM) and ATP (1 mM). In each case, 200 μM MTSES (black bars) or MTSET (white bars) was applied to the cytoplasmic face of the patch at time
zero. The decline in current amplitude due to MTS modiﬁcation has been ﬁt by a single-exponential function in each case. Currents remaining in the
presence of MTSES or MTSET were inhibited by application of 5 μM CFTRinh-172 as indicated. (C) Calculated modiﬁcation rate constants for both
MTSES (●) and MTSET (○) for each of the 14 MTS reagent-sensitive mutants listed. Note that T943C, V944C, and R975C were inhibited by
MTSES but not by MTSET (see Figure 4). Means of data from three patches are shown. Asterisks indicate a signiﬁcant diﬀerence between the
modiﬁcation rate constant for MTSES and that for MTSET (p < 0.05).
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generate constitutively active (ATP-independent) channel,
formed a central part of the hypothesis put forward by Wang
et al.
18 concerning the role of CL3 in channel gating. It was a
great surprise to us, therefore, that we were unable to observe
functional expression of K978C in our experiments (Figure 3),
especially as Wang et al.
18 had also studied this mutant in a
Cys-less background. Because we were so surprised at not being
able to replicate the functional expression of this mutant, we in
fact constructed this mutant on three independent occasions,
but in each case, the lack of fuctional expression remained the
same. We can only imagine that some diﬀerence in the
expression system has resulted in our failure to observe currents
for this mutant. Indeed, our results indicate that this mutant is
associated with a severe protein processing defect in BHK cells
(Figure 2). In fact, the functional results of Wang et al.
18 for
K978C, that the open probability of the channel is reduced
following modiﬁcation by MTSET, are quite consistent with
our own ﬁndings for other, nearby CL3 residues.
Our focus in this work was to explore the functional
properties of CL3 mutants that do express functional channels
in the membrane of BHK cells. We found that 14 of 16
functional cysteine-substituted mutants were sensitive to
cytoplasmic exposure to MTSES and/or MTSET (Figure 4).
This suggests that most of the juxtamembrane parts of CL3
(Figure 1) are exposed to the cytoplasm and readily accessible
to large cytoplasmic substances. In fact, there was no apparent
diﬀerence between those mutations located proximal to TM8
compared to those proximal to TM9, in terms of the functional
eﬀect of modiﬁcation (Figure 4) or the rate of modiﬁcation
(Figure 5), suggesting that these two “limbs” of CL3 show
approximately equivalent accessibilities to the cytoplasm. We
Figure 6. Single-channel conductance of cysteine mutants. (A) Example single-channel currents carried by Cys-less CFTR and the charge-
substituting mutants K946C and R975C as indicated, at a membrane potential of −50 mV. The horizontal line to the left of the traces indicates the
channel closed state current level. (B and C) Mean single-channel I−V relationships recorded under these conditions for Cys-less (○), K946C (●,
B), and R975C (●, C). (D) Mean single-channel conductance for diﬀerent channel variants measured under these conditions. None of these were
signiﬁcantly diﬀerent from the Cys-less background. Means of data from three to twelve patches are shown in panels C and D.
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that consistently resulted from MTSES and/or MTSET
modiﬁcation of CL3 (Figure 4) could reﬂect a reduction in
Cl− conductance (i.e., interference with the movement of Cl−
through the open channel pore) and/or a reduction in open
probability (i.e., interference with the normal opening and
closing of the channel). Direct single-channel recording
experiments with MTSES (Figures 7 and 8) support the latter
explanation. However, we have additional reasons to doubt an
important functional role for CL3 in inﬂuencing the functional
properties of the permeation pathway for Cl− ions.
We
2,28,30 and others
3,29 have recently used cytoplasmic MTS
reagents to identify pore-lining amino acid side chains in TM1,
TM6, and TM12, and several patterns emerge from these
studies. In each of these studies, MTSES modiﬁcation inside
the pore always causes a reduction in channel function, most
likely because of interference with Cl− permeation. This
contrasts with MTSES modiﬁcation of CL3, which has no eﬀect
on Cl− conductance (Figure 8A). It would be most surprising if
introduction of a negative charge by covalent modiﬁcation by
MTSES close to the permeation pathway for Cl− ions did not
alter Cl− conductance. The rate of MTSES modiﬁcation is high
for cysteines introduced close to the cytoplasmic ends of the
TMs and decreases with the apparent distance into the pore
from its cytoplasmic end, consistent with narrowing of the
pore.
2,28,30 In contrast, there was no apparent pattern to the
rate of MTS modiﬁcation of diﬀerent CL3 residues (Figure 5).
Importantly, in TM1 the rate of modiﬁcation by positively
charged MTSET is consistently ∼10-fold lower than that by
negatively charged MTSES, which was interpreted as reﬂecting
the function of the CFTR channel as an anion-selective pore.
30
In contrast, although some diﬀerences in the rate of MTSES
versus MTSET modiﬁcation were observed for some CL3
residues (Figure 5), there was no consistent pattern suggestive
of an overall anion selectivity of this region of CFTR. Instead,
we suggest that local factors may result in the small diﬀerences
in the rate of MTSES versus MTSET modiﬁcation measured at
speciﬁc CL3 residues (Figure 5). The eﬀects of cysteine
substitutions per se also do not support an important role for
the juxtamembrane regions of CL3 in the Cl− permeation
pathway. None of the mutants studied altered the shape of the
macroscopic I−V curve (Figure S1 of the Supporting
Information) or the single-channel conductance (Figure 6),
even though both of these parameters are highly sensitive to
cysteine substitutions both in the TMs
28,29,33,39−42 and in the
ELs that are thought to contribute to the outer mouth of the
pore.
4,5 The shapes of the I−V relationships were also not
altered by MTSES or MTSET modiﬁcation (Figure S1 of the
Supporting Information), even though the charge deposition
associated with MTS modiﬁcation often aﬀects the rectiﬁcation
of the I−V relationship for cysteines located close to the Cl−
permeation pathway.
4,5,28,33,41,42
Overall, our ﬁndings suggest that, even though molecular
models of CFTR suggest that the juxtamembrane region of
CL3 might contribute to a restricted region of a central “pore”
through the MSDs (Figure 1), this region does not make a
suﬃciently important functional contribution to the channel to
signiﬁcantly inﬂuence Cl− permeation. One possibility is that
CL3 does line the aqueous lumen of the pore, but that Cl− ions
do not approach close enough to CL3 for their movement to be
inﬂuenced by the properties of individual amino acid side
chains here. This would imply that the open pore is very wide
at the level of the CLs, much wider than in the TMs where Cl−
ions certainly do interact with pore-lining side chains. This
suggestion would be consistent with longstanding functional
data suggesting the pore has a deep and wide inner vestibule
that is readily accessible to large cytoplasmic substances in open
channels.
1,43 However, it is in direct contrast with the idea,
Figure 7. Example of the eﬀect of modiﬁcation by MTSES on single-channel currents. (A) Current recorded from a patch containing two I982C
channels, before (Control) and after addition of 200 μM MTSES to the intracellular solution, at a membrane potential of −20 mV. The horizontal
line to the left of the traces indicates the zero current level. (B) All-points amplitude histograms prepared from extended periods of the recordings
shown in panel A, corresponding to control (left) and post-MTSES (right) conditions. Each has been ﬁt by the sum of three Gaussian functions,
giving mean unitary amplitudes of −0.504 pA (control) and −0.488 pA (+MTSES) and open probabilities of 0.183 (control) and 0.101 (+MTSES).
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narrow region of the pore (Figure 1).
11 It is also possible that
other CLs make a more important functional contribution than
CL3 does, although the model shown in Figure 1 suggests a
fairly symmetrical contribution of all four CLs to the apparent
central pore. An alternative possibility is that this central pore
apparently formed by the CLs (Figure 1C) is not part of the
Cl− permeation pathway at all. In some ion channel types, the
permeant ion does not follow a direct pathway along the central
axis of the entire protein but instead enters and exits a central
transmembrane pore via lateral “portals” located close to the
cytoplasmic side of the membrane.
44−48 There is no functional
evidence of the existence of such portals in CFTR, although we
would point out that there is also no direct evidence that Cl−
ions enter the permeation pathway at the cytoplasmic end of
the CLs and pass along the extent of the central axis of the
channel protein. Interestingly, a recent direct structural study of
CFTR suggested that portals might exist at the TM5−CL2 and
TM11−CL4 cytoplasmic boundaries.
49 In many ABC proteins,
the substrate translocation pathway is partially open to part of
the lipid bilayer, raising the possibility that some substrates
enter and exit via the bilayer.
50 As described by Bai et al.,
29 such
an opening to the bilayer, which can actually be observed at the
extracellular end of the CFTR structural model of Figure 1A, is
inconsistent with the function of CFTR as an ion channel.
Nevertheless, these openings do raise the precedent that ABC
protein substrates do not necessarily follow an unwaveringly
central path through the protein.
Our results do support the previously suggested role for CL3
in gating of the CFTR channel.
14−18 MTSES modiﬁcation of 14
of 16 functional cysteine-substituted mutants led to a decrease
in channel open probability (Figure 8B), even though the
mutations themselves did not appear to have dramatic eﬀects
on open probability (Figure S2 of the Supporting Information).
In most cases, MTSET had a similar eﬀect (Figure 4),
indicating a lack of strong charge dependence in the functional
eﬀects of modiﬁcation. The consistent eﬀects of MTS
modiﬁcation (Figure 4) argue against a speciﬁc role for
individual amino acid side chains in CL3 in channel gating and
instead suggest that changes in the structure of this CL exert a
relatively nonspeciﬁce ﬀect on gating. This would appear to be
consistent with the hypothesis put forward by Wang et al.
18 that
CL3 forms a “compression spring” that regulates the opening
and closing of the channel. Modiﬁcation by MTS reagents may
then stiﬀen the spring and reduce the open probability in a
relatively position-independent fashion. This hypothesis
emphasizes the role of the CLs in transmitting gating
information “forward” from the NBDs to the pore. It is also
possible that the CLs are involved in transmitting gating
information “backward”, i.e., that changes in the structure of
CL3 feed back to modify NBD function, ultimately resulting in
a change in channel gating.
29,51 Irrespective of the precise
mechanism, our similar results for mutations in the two limbs of
Figure 8. Eﬀects of MTSES on the single-channel current amplitude and open probability. Single-channel recordings such as those shown in Figure
7 were used to quantify the eﬀect of MTSES (200 μM) on the single-channel current amplitude (A) and open probability (B) for each of the channel
variants named. Means of data from three to nine patches are shown. Asterisks indicate a signiﬁcant diﬀerence from Cys-less (p < 0.05).
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roles. Furthermore, because MTS modiﬁcation of most residues
resulted in a similar, ∼25−75% inhibition of the macroscopic
current amplitude, it might be considered that no sites in CL3
are absolutely essential to channel function, perhaps pointing to
a role of this region as a mediator, rather than a controller, of
channel gating.
In summary, our comprehensive functional screening of CL3
suggests that this region of CFTR is readily accessible to the
cytoplasm, where it plays a role in the control of channel gating.
This is consistent with the prevailing idea that CL3 forms the
link between the site of ATP action (the NBDs) and the
opening and closing of a channel gate located in the TMs.
However, our results do not support the hypothesis that this
region is close enough to the Cl− permeation pathway to exert
any inﬂuence on permeating Cl− ions.
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